Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 26, 1991 - Issue 3
Submit an article Journal homepage
36
Views
68
CrossRef citations to date
0
Altmetric
Original Article

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

L. Lundell Dept. of Surgery, Sahlgren's Hospital, Gothenburg, Sweden
,
L. Backman Dept. of Surgery, Danderyd's Hospital, Danderyd, Sweden
,
P. Ekström Dept. of Surgery and Medicine, Sandviken's Hospital, Sandviken, Sweden
,
L.-K. Enander Dept. of Surgery, Central Hospital, Karlstad, Sweden
,
S. Falkmer Dept. of Tumour Pathology, Karolinska Institute and Hospital, Stockholm, Sweden
,
O. Fausa Dept. of Pathology, University Hospital, Uppsala, Sweden
,
L. Grimelius Dept. of Pathology and Safety Assessments, Astra, Södertälje, Sweden
,
N. Havu Dept. of Otorhinolaryngology, Medical Centre Hospital, Örebro, Sweden
,
T. Lind Dept. of Surgery, University Hospital, Umeå, Sweden
,
H. Lönroth Dept. of Clinical Pharmacology and Medicine, Hässle, Mölndal, Sweden
,
S. Sandmark Dept. of Medicine, Rikshospitalet, Oslo, Norway
,
B. Sandzén Dept. of Surgery, Sahlgren's Hospital, Gothenburg, Sweden
,
P. Unge Dept. of Surgery, Sahlgren's Hospital, Gothenburg, Sweden
&
I. H. Westin Dept. of Surgery, Sahlgren's Hospital, Gothenburg, Sweden
 show all
Pages 248-256 | Received 27 Jun 1990, Accepted 20 Aug 1990, Published online: 08 Jul 2009

Citations (68)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Robert M. Kroes, Mattijs E. Numans, Roger H. Jones, Niek J. de Wit & Theo JM Verheij. (1999) Original Paper: Gastro-oesophageal reflux disease in primary care Comparison and evaluation of existing national guidelines and development of uniform European guidelines. European Journal of General Practice 5:3, pages 88-97.
Read now
M. Viljakka, J. Nevalainen & J. Isolauri. (1997) Lifetime Costs of Surgical versus Medical Treatment of Severe Gastro-Oesophageal Reflux Disease in Finland. Scandinavian Journal of Gastroenterology 32:8, pages 766-772.
Read now
J. Hansky. (1996) Reflux Disease: the View of the Internist. Scandinavian Journal of Gastroenterology 31:sup220, pages 63-65.
Read now
G. Van Den Boom, P. M. M. Y. H. Go, W. Hameeteman, B. Dallemagne & A. J. H. A. Ament. (1996) Cost Effectiveness of Medical versus Surgical Treatment in Patients with Severe or Refractory Gastroesophageal Reflux Disease in The Netherlands. Scandinavian Journal of Gastroenterology 31:1, pages 1-9.
Read now
L. Sterk Laursen, T. Havelund, S. Bondesen, J. Hansen, G. Sanchez, E. Sebelin, C. Fenger & K. Lauritsen. (1995) Omeprazole in the Long-Term Treatment of Gastro-oesophageal Reflux Disease: A Double-Blind Randomized Dose-Finding Study. Scandinavian Journal of Gastroenterology 30:9, pages 839-846.
Read now
L. Lundell. (1994) Long-Term Treatment of Gastro-Oesophageal Reflux Disease with Omeprazole. Scandinavian Journal of Gastroenterology 29:sup201, pages 74-78.
Read now
T. Havelund, L. S. Laursen & K. Lauritsen. (1994) Efficacy of Omeprazole in Lower Grades of Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 29:sup201, pages 69-73.
Read now
E. C. Klinkenberg-Knol. (1991) Recent Advances in the Management of Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 26:sup188, pages 101-107.
Read now

Articles from other publishers (60)

Amir Mari, Wasef Na’amnih, Aiman Gahshan, Helal Saied Ahmad, Tawfik Khoury & Khitam Muhsen. (2022) Comparison in Adherence to Treatment between Patients with Mild–Moderate and Severe Reflux Esophagitis: A Prospective Study. Journal of Clinical Medicine 11:11, pages 3196.
Crossref
Hiroto Miwa, Ataru Igarashi, Lida Teng, Akihito Uda, Hisato Deguchi & Toshiro Tango. (2019) Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease. Journal of Gastroenterology 54:8, pages 718-729.
Crossref
Tawfik Khoury, Amir Mari, Hana Amara, Mohamed Jabaren, Abdulla Watad, Wiliam Nseir, Wisam Sbeit & Mahmud Mahamid. (2019) Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology and Hepatology 2019, pages 1-7.
Crossref
Taline A Boghossian, Farah Joy Rashid, Wade Thompson, Vivian Welch, Paul Moayyedi, Carlos Rojas-Fernandez, Kevin Pottie & Barbara Farrell. (2017) Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Clare Donnellan, Cathy Preston, Paul Moayyedi & Nav Sharma. (2010) Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database of Systematic Reviews.
Crossref
J. LABENZ, D. ARMSTRONG, S. ZETTERSTRAND, S. EKLUND & A. LEODOLTER. (2009) Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis - results from the maintenance phase of the EXPO study. Alimentary Pharmacology & Therapeutics 29:11, pages 1165-1171.
Crossref
Ernst Eypasch, Edmund A.M. Neugebauer, F. Fischer, Hans Troidl, A.L. Blum, D. Collet, A. Cuschieri, B. Dallemagne, H. Feussner, K.-H. Fuchs, H. Glise, C.K. Kum, T. Lerut, L. Lundell, H.E. Myrvold, A. Peracchia, H. Petersen & J.J.B. van Lanschot. 2006. EAES Guidelines for Endoscopic Surgery. EAES Guidelines for Endoscopic Surgery 97 124 .
P. M. Wilkerson, J. Stratford, L. Jones, J. Sohanpal, M. I. Booth & T. C. B. Dehn. (2005) A poor response to proton pump inhibition is not a contraindication for laparoscopic antireflux surgery for gastro esophageal reflux disease. Surgical Endoscopy 19:9, pages 1272-1277.
Crossref
Brigitte Schumacher, Horst Neuhaus, Marianne Ortner, Ren?? Laugier, Martin Benson, Jean Boyer, Thierry Ponchon, Friedrich Hagenm??ller, Jean-Charles Grimaud, Patrick Rampal, Jean-Francois Rey, Karl-Hermann Fuchs, Hans-Peter Allgaier, J??rgen Hochberger, Hubert J Stein, Juan Andr??s Ram??rez Armengol, Peter D Siersema & Jacques Devi??re. (2005) Reduced Medication Dependency and Improved Symptoms and Quality of Life 12 Months After Enteryx Implantation for Gastroesophageal Reflux. Journal of Clinical Gastroenterology 39:3, pages 212-219.
Crossref
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology 13 54 .
Clare Donnellan, Cathy Preston, Paul Moayyedi & Nav Sharma. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Mercedes Domínguez Antonaya, Diego Moreno Sánchez & Raquel González Alonso. (2004) Estrategias terapéuticas en la enfermedad por reflujo gastroesofágico no erosiva. Medicina Clínica 123:9, pages 352-356.
Crossref
David A. Johnson, Robert Ganz, James Aisenberg, Lawrence B. Cohen, Jacques Deviere, T. Raymond Foley, Gregory B. Haber, Jeffrey H. Peters & Glen A. Lehman. (2003) Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. The American Journal of Gastroenterology 98:9, pages 1921-1930.
Crossref
J. H. S. You, A. C. M. Lee, S. C. Y. Wong & F. K. L. Chan. (2003) Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis. Alimentary Pharmacology & Therapeutics 17:6, pages 785-792.
Crossref
Alberto Pilotto, Marilisa Franceschi, Gioacchino Leandro, Romeo Novello, Francesco Di Mario & Gianni Valerio. (2002) Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study. American Journal of Therapeutics 9:4, pages 295-300.
Crossref
C. J. J. Mulder, B. D. Westerveld, J. M. Smit, M. Oudkerk Pool, M. H. Otten, T. G. Tan, A. W. M. van Milligen de Wit & G. H. de Groot. (2002) A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. European Journal of Gastroenterology & Hepatology 14:6, pages 649-656.
Crossref
J. J. Ofman, G. H. Dorn, M. B. Fennerty & R. Fass. (2002) The clinical and economic impact of competing management strategies for gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 16:2, pages 261-273.
Crossref
James W. Freston, Robert L. Jackson, Bidan Huang & E. David BallardIIII. (2002) Lansoprazole for Maintenance of Remission of Erosive Oesophagitis. Drugs 62:8, pages 1173-1184.
Crossref
K. H. Moore, P. Barry, J. Burn & G. Falk. (2001) Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study. Diseases of the Esophagus 14:1, pages 17-22.
Crossref
Patrick G Jackson, Michael A Gleiber, Reza Askari & Stephen R.T Evans. (2001) Predictors of outcome in 100 consecutive laparoscopic antireflux procedures. The American Journal of Surgery 181:3, pages 231-235.
Crossref
J. A. Todd, T. Weston, T. M. Macdonald, D. A. Johnston & J. F. Dillon. (2008) The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett’s oesophagus and oesophagitis. Alimentary Pharmacology & Therapeutics 15:2, pages 221-226.
Crossref
Laine, Ahnen, Mcclain, Solcia & Walsh. (2001) Review article: potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors. Alimentary Pharmacology & Therapeutics 14:6, pages 651-668.
Crossref
Ph. Houcke, D. Goldfain, P. Guyot, Th. Helbert, J. Laurent, J. F. Rey, D. Rouhier, J. Cassigneul, B. Marchetti, A. Papazian & M. Laurence. (2000) Prévention des récidives de l’oesophagite par reflux par le lansoprazole: 30 mg un jour sur deux ou 15 mg tous les jours?Prevention of relapse of gastro-oesophageal reflux disease by lansoprazole: 30 mg every other day or 15 mg daily?. Acta Endoscopica 30:3, pages 243-253.
Crossref
Gustavo R. Heudebert, Robert M. Centor, Joshua C. Klapow, Robert Marks, Lawrence Johnson & C. Mel Wilcox. (2000) What is heartburn worth?. Journal of General Internal Medicine 15:3, pages 175-182.
Crossref
Yeomans & Dent. (2001) Personal review: alarmism or legitimate concerns about long‐term suppression of gastric acid secretion?. Alimentary Pharmacology & Therapeutics 14:3, pages 267-271.
Crossref
Lauren B Gerson, Anthony S Robbins, Alan Garber, John Hornberger & George Triadafilopoulos. (2000) A Cost-Effectiveness Analysis of Prescribing Strategies in The Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 95:2, pages 395-407.
Crossref
Ronald A. Hinder, Jeffrey S. Libbey, Piotr Gorecki & Tanja Bammer. (1999) ANTIREFLUX SURGERY. Gastroenterology Clinics of North America 28:4, pages 987-1005.
Crossref
Ziad Younes & David A. Johnson. (1999) DIAGNOSTIC EVALUATION IN GASTROESOPHAGEAL REFLUX DISEASE. Gastroenterology Clinics of North America 28:4, pages 809-830.
Crossref
C. J. Van Rensburg, Honiball, J. H. Van Zyl, H. DE K. Grundling, Eloff, Spies, Simjee, Theron, Fischer & Louw. (2001) Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis—a 2‐year follow‐up. Alimentary Pharmacology & Therapeutics 13:8, pages 1023-1028.
Crossref
Henk P. M. Festen, Ed Schenk, Gie Tan, Pleun Snel & Frits Nelis. (1999) Omeprazole Versus High-Dose Ranitidine in Mild Gastroesophageal Reflux Disease: Short- and Long-Term Treatment. American Journal of Gastroenterology 94:4, pages 931-936.
Crossref
Werner Creutzfeldt. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors 91 115 .
Petrus J. Pauwels & Thierry Wurch. (1998) Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors. Molecular Neurobiology 17:1-3, pages 109-135.
Crossref
Carling, Axelsson, Forssell, Stubberöd, Kraglund, Bonnevie & Ekström. (2001) Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long‐term comparative study. Alimentary Pharmacology & Therapeutics 12:10, pages 985-990.
Crossref
Isabelle Chabot, Johanne Morin, Kateri Bourbeau & Jocelyne Moisan. (2016) A Comparison of Retrospective and Concurrent Drug Utilization Review of Omeprazole. Journal of Pharmacy Technology 14:5, pages 202-208.
Crossref
L. LUNDELL. (2010) New information relevant to long-term management of endoscopy-negative reflux disease. Alimentary Pharmacology & Therapeutics 11, pages 93-98.
Crossref
William R. Garnett & Susan M. Garabedian‐Ruffalo. (2012) Identification, Diagnosis, and Treatment of Acid‐Related Diseases in the Elderly: Implications for Long‐Term Care. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:5, pages 938-958.
Crossref
I.C.Eric Wesdorp, Willem Dekker & Henk P.M Festen. (1997) Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Clinical Therapeutics 19:5, pages 1048-1057.
Crossref
J.-P. Galmiche, P. Barthelemy & B. Hamelin. (1997) Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Alimentary Pharmacology and Therapeutics 11:4, pages 765-773.
Crossref
R. Lambert. (1997) Current practice and future perspectives in the management of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 11:4, pages 651-662.
Crossref
N. I. McDougall, R. G. P. Watson, J. S. A. Collins, R. J. McFarland & A. H. G. Love. (1997) Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial. Alimentary Pharmacology and Therapeutics 11:3, pages 487-495.
Crossref
Ryan A Harris, Miriam Kuppermann & Joel E Richter. (1997) Prevention of Recurrences of Erosive Reflux Esophagitis: A Cost-Effectiveness Analysis of Maintenance Proton Pump Inhibition. The American Journal of Medicine 102:1, pages 78-88.
Crossref
K.-H. Fuchs & S. M. Freys. 1997. Gastrointestinale Funktionsstörungen. Gastrointestinale Funktionsstörungen 605 610 .
N I McDougall, B T Johnston, F Kee, J S Collins, R J McFarland & A H Love. (1996) Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.. Gut 38:4, pages 481-486.
Crossref
Stephen E. Silvis, Mahnaz Farahmand, June A. Johnson, Howard J. Ansel & Samuel B. Ho. (1996) A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis. Gastrointestinal Endoscopy 43:3, pages 216-221.
Crossref
Sergio Vigneri, Rosanna Termini, Gioacchino Leandro, Salvatore Badalamenti, Maurizio Pantalena, Vincenzo Savarino, Francesco Di Mario, Giuseppe Battaglia, Giuseppe Sandro Mela, Alberto Pilotto, Mario Plebani & Giovanni Davi. (1995) A Comparison of Five Maintenance Therapies for Reflux Esophagitis. New England Journal of Medicine 333:17, pages 1106-1110.
Crossref
R. F. McCloy, R. Arnold, K. D. Bardhan, D. Cattan, E. Klinkenberg-Knol, P. N. Maton, R. H. Riddell, P. Sipponen & A. Walan. (1995) Pathophysiological effects of long-term acid suppression in man. Digestive Diseases and Sciences 40:S2, pages 96S-120S.
Crossref
M. Brian Fennerty & David Lieberman. (1994) H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: “For whom the bell tolls”. Gastroenterology 107:5, pages 1545-1548.
Crossref
Bengt Hallerbäck, Peter Unge, Lasse Carling, Björn Edwin, Hans Glise, Nilu Havu, Ebbe Lyrenäs & Kjell Lundberg. (1994) Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 107:5, pages 1305-1311.
Crossref
G. BIANCHI PORRO, R. CORINALDESI, M. LAZZARONI, L. BARBARA, L. CAPURSO, P. PAOLUZI, A. MANGIAMELI, F. SABBATINI, M. FRANCESCHI & E. BOLLING. (2007) Long term treatment with omeprazole 20 mg three days a week or 10 mg daily in the prevention of duodenal ulcer relapse. Alimentary Pharmacology & Therapeutics 8:5, pages 541-548.
Crossref
Vincenzo Savarino, Giuseppe Sandro Mela, Patrizia Zentilin, Patrizia Cutela, Maria Raffaella Mele, Daniele Perilli, Ambrogio Vassallo, Adriana Zambotti, Carlo Mansi & Guido Celle. (1994) Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. Digestive Diseases and Sciences 39:7, pages 1473-1482.
Crossref
. (2012) Questions and Answers. PharmacoEconomics 5:S3, pages 68-73.
Crossref
J Dent, N D Yeomans, M Mackinnon, W Reed, F M Narielvala, D J Hetzel, E Solcia & D J Shearman. (1994) Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.. Gut 35:5, pages 590-598.
Crossref
W. A. De BOER & G. N. J. TYTGAT. (2007) Review article: drug therapy for reflux oesophagitis. Alimentary Pharmacology & Therapeutics 8:2, pages 147-157.
Crossref
Jens F. Rehfeld & Wouter W. Van Solinge. 1994. 295 347 .
H. L. WALDUM, E. BRENNA, P. M. KLEVELAND, A. K. SANDVIK & U. SYVERSEN. (2007) Review article: the use of gastric acid‐inhibitory drugs—physiological and pathophysiological considerations. Alimentary Pharmacology & Therapeutics 7:6, pages 589-596.
Crossref
C. M. BATE, S. N. BOOTH, J. P. CROWE, B. HEPWORTH-JONES, M. D. TAYLOR & P. D. I. RICHARDSON. (2007) Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?. Alimentary Pharmacology & Therapeutics 7:5, pages 501-507.
Crossref
W Inauen, C Emde, B Weber, D Armstrong, H U Bettschen, T Huber, U Scheurer, A L Blum, F Halter & H S Merki. (1993) Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.. Gut 34:8, pages 1025-1031.
Crossref
S. J. SONTAG. (2007) Rolling review: gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 7:3, pages 293-312.
Crossref
J. W. FRESTON. (2007) Future prospects for proton pump inhibitors. Alimentary Pharmacology & Therapeutics 7, pages 68-75.
Crossref
M.J. Arens & J. Dent. (1993) Acid pump blockers: what are their current therapeutic roles?. Baillière's Clinical Gastroenterology 7:1, pages 95-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.